Barclays
ETNB

Barclays’s 89bio ETNB Stock Holding History

Barclays’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,600
Closed -$116K – 4691
2023
Q1 		$116K Buy
+7,600
New +$99.1K ﹤0.01% 4100

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's ETNB Position: Q4 2025 in Review

Barclays sold out of 89bio (ETNB) in Q4 2025, closing a stake of 527,069 shares — an estimated $7.75M sold.

Barclays first reported a position in ETNB in Q1 2022 and held it in 15 quarters. The position peaked at $9.64M in Q3 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Barclays reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 527,069 89bio shares in Q4 2025, an estimated $7.75M.
  • Barclays first reported a position in 89bio in Q1 2022 and held it in 15 quarters.
  • Barclays's 89bio position peaked at $9.64M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.